
New $100M fund to invest in pre-revenue medical device and digital health startups
This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million.
This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million.
The Israeli company's technology uses the power of focused ultrasound guided by MR imaging to target conditions like essential tremor, Parkinson's disease and neuropathic pain.
Medial EarlySign is hoping to leverage the power of artificial intelligence to identify patients at high risk for certain diseases to bend overall cost curve and benefit patients.
Nerivio Migra consists of a bioelectric patch which is placed on the upper arm and an associated smartphone app which controls the electrical impulses and records data.
The FDA decision, which builds on a prior approval of the company's algorithm for the detection of intracranial hemorrhages through CT scans, is part of a larger vision sketched out by CEO Elad Walach of plugging new algorithms into the Aidoc system to create a new standard of care in radiology.
The product, HealthPNX, automatically flags findings suggestive of pneumothorax based on chest X-rays or digital radiography scans and informs the medical team.
TytoCare's TytoHome product will be offered online through BestBuy.com and brick-and-mortar stores in Minnesota. Availability is also coming soon to locations in California, North Dakota and South Dakota.
Avi Veidman was prompted to create the Tel Aviv-based company, Nucleai, after witnessing his father anxiously wait about 30 days to receive his biopsy results.
Here's how providers at the Hospital Israelita Albert Einstein in Brazil take care of workers on an oil platform away from the continent.
The company raised a $33.5 million Series C round that included participation from rural healthcare system Sanford Health, Chinese insurer Ping An and global pharmacy chain Walgreens.
Healthy.io's urinalysis testing kit - dubbed Dip.io - uses disposable strips and cups in conjunction with a smartphone camera to read and interpret results.
An Israeli startup, Accelerated Evolution Biosciences, or AEBi, claimed it has a "complete cure for cancer" on the way. A newspaper gave the company glowing coverage it didn't deserve.
The majority of the funding came from hospital bed manufacturer Hill-Rom and Wells Fargo Strategic Capital, the venture capital and growth equity investment arm of Wells Fargo & Company.
Earlier this year, the company, which raised $3.5 million in 2016, revealed the findings of a three-month study of its technology conducted at Johns Hopkins University.
The program from IBM Israel and Hadassah Medical Center, which will begin in the first quarter of 2019 and last six months, is open to startups that have completed a post-seed round of financing, according to Israeli publication Globes.